Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Susan Calabrese"'
Autor:
Erica S. Tsang, Rahul R. Aggarwal, Mallika S. Dhawan, Emily K. Bergsland, Edwin A. Alvarez, Susan Calabrese, Romain Pacaud, Jose Garcia, Delaire Fattah, Scott Thomas, Jennifer Grabowsky, Mark M. Moasser, Pamela N. Munster
Publikováno v:
Cancer Research Communications. 2:570-576
The PI3K pathway may be a potential mechanism to overcome cisplatin resistance. We conducted a phase Ib trial of alpelisib and cisplatin for patients with solid tumor malignancies with planned dose expansion in HPV-associated tumors. The primary obje
Autor:
Nitya Raj, Jennifer A. Chan, Stephanie J. Wang, Rahul R. Aggarwal, Susan Calabrese, April DeMore, Lawrence Fong, Jennifer Grabowsky, Thomas A. Hope, Kanti Pallav Kolli, Claire K. Mulvey, Pamela N. Munster, Kimberly Perez, Sippy Punn, Diane Reidy-Lagunes, Sofia Von Fedak, Li Zhang, Emily K. Bergsland
Publikováno v:
British Journal of Cancer.
Autor:
Pamela N. Munster, Mark M. Moasser, Jennifer Grabowsky, Scott Thomas, Delaire Fattah, Jose Garcia, Romain Pacaud, Susan Calabrese, Edwin A. Alvarez, Emily K. Bergsland, Mallika S. Dhawan, Rahul R. Aggarwal, Erica S. Tsang
The PI3K pathway may be a potential mechanism to overcome cisplatin resistance. We conducted a phase Ib trial of alpelisib and cisplatin for patients with solid tumor malignancies with planned dose expansion in HPV-associated tumors. The primary obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5185da53f97a26f3cf85290739ff67de
https://doi.org/10.1158/2767-9764.c.6550920.v1
https://doi.org/10.1158/2767-9764.c.6550920.v1
Autor:
Pamela N. Munster, Mark M. Moasser, Jennifer Grabowsky, Scott Thomas, Delaire Fattah, Jose Garcia, Romain Pacaud, Susan Calabrese, Edwin A. Alvarez, Emily K. Bergsland, Mallika S. Dhawan, Rahul R. Aggarwal, Erica S. Tsang
A) Rationale for study drug dose interruption or reduction; B) Rationale for cisplatin dose interruption or reduction; C) Cisplatin dose intensity, stratified by dose level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15538f083c9f21c5743c59ccfc7bbc42
https://doi.org/10.1158/2767-9764.22545363.v1
https://doi.org/10.1158/2767-9764.22545363.v1
Autor:
Julia Carnevale, Rahul Aggarwal, M. Howell, Emma Dean, Neel Shah, Pamela N. Munster, Jennifer A. Grabowsky, Susan Calabrese, Mallika Sachdev Dhawan, Sarah E. Umetsu, Jocelyn S. Chapman, Eric A. Collisson, Edwin A. Alvarez, Simon Smith, L. Wilch
Publikováno v:
Annals of Oncology. 32:S583
Autor:
Lawrence Fong, Jennifer A. Chan, Delaire Fattah, Nitya Raj, Rahul Aggarwal, Kimberly Perez, Thomas A. Hope, Li Zhang, Jennifer A. Grabowsky, April DeMore, Diane Lauren Reidy, Pamela N. Munster, Kanti Pallav Kolli, Emily K. Bergsland, Mallika Sachdev Dhawan, Susan Calabrese, Sofia Von Fedak
Publikováno v:
Journal of Clinical Oncology. 39:4148-4148
4148 Background: The efficacy of immune checkpoint inhibitor (CPI) therapy has not been established in extrapulmonary poorly differentiated neuroendocrine carcinomas (EP-PDNECs). In small cell lung cancer, CPI therapy is approved for use in the first
Autor:
Nela Pawlowska, Phu Lam, Kathleen Comerford, Scott Thomas, Rahul Aggarwal, Daphne Bautista, Pamela N. Munster, Susan Calabrese, Jennifer A. Grabowsky
Publikováno v:
Journal of Clinical Oncology. 37:3022-3022
3022 Background: We previously reported the initial phase 1b study results of PAZ + ABX, a potent pan-HDAC inhibitor, demonstrating acceptable toxicity profile and encouraging anti-tumor activity (Aggarwal et al. JCO 2017). We report the long-term fo
Autor:
Claire Mulvey, Nitya Prabhakar Raj, Jennifer A. Chan, Rahul Raj Aggarwal, Pelin Cinar, Thomas A Hope, Kanti Kolli, Li Zhang, Susan Calabrese, Jennifer Ann Grabowsky, Lila Modarresi, Virginia Kelly, Danielle Stonely, Pamela N. Munster, Diane Lauren Reidy, Lawrence Fong, Emily K. Bergsland
Publikováno v:
Journal of Clinical Oncology. 37:363-363
363 Background: Immune checkpoint inhibitor (CPI) efficacy has not been established in extrapulmonary poorly-differentiated neuroendocrine carcinomas (EP-PDNECs). In small cell lung cancer, promising antitumor activity of CPI led to accelerated appro
Autor:
Emily K. Bergsland, Susan Calabrese, Tom Hope, Pelin Cinar, Claire Hooker, Jennifer A. Grabowsky, Jenna Zhang, Nitya Raj, Kanti Pallav Kolli, Li Zhang, Lawrence Fong, Jennifer A. Chan, Rahul Aggarwal
Publikováno v:
Journal of Clinical Oncology. 36:TPS4147-TPS4147
TPS4147Background: The efficacy of immune checkpoint inhibitors (CPI) has not been established in extrapulmonary high grade neuroendocrine carcinomas (EP-HGNECs), a disease for which additional tre...
Autor:
Christopher E. Sotto, Jeremy W. Gordon, Zihan Zhu, Michael A. Ohliger, Rahul Aggarwal, Pamela N. Munster, Jim Slater, Susan Calabrese, Robert Bok, Daniel B. Vigneron, John Kurhanewicz, Emily Boyd
Publikováno v:
Journal of Clinical Oncology. 36:e24168-e24168
e24168Background: The PI3K/mTOR pathway is a relevant therapeutic target yet real-time monitoring of pathway inhibition is challenging. Metabolic MR imaging using hyperpolarized 13C-pyruvate provid...